HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 74 | 78 | 94.9% | |
| HF004 | 2020 | 79 | 83 | 95.2% | |
| HF006 | 2021 | 95 | 98 | 96.9% | |
| HF006 | 2022 | 98 | 102 | 96.1% | |
| HF006 | 2023 | 109 | 110 | 99.1% |
